Journey Medical (DERM) News Today $6.88 +0.13 (+1.93%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Tang Capital Management LLC Invests $6.75 Million in Journey Medical Co. (NASDAQ:DERM)Tang Capital Management LLC acquired a new position in Journey Medical Co. (NASDAQ:DERM - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,725,569 shares of the company's stock, valued at approximately $6,747,000. Tang Capital ManagemMay 20 at 6:24 AM | marketbeat.comRoth Capital Lowers Earnings Estimates for Journey MedicalJourney Medical Co. (NASDAQ:DERM - Free Report) - Stock analysts at Roth Capital reduced their Q2 2025 earnings per share estimates for Journey Medical in a report issued on Thursday, May 15th. Roth Capital analyst J. Wittes now expects that the company will post earnings of ($0.08) per share forMay 20 at 1:49 AM | marketbeat.comJourney Medical Q2 EPS Forecast Decreased by Roth CapitalMay 20 at 1:49 AM | americanbankingnews.comJourney Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comJourney Medical outlines Emrosi launch momentum and targets expanded payer access in 2025May 15, 2025 | msn.comJourney Medical Corp (DERM) Q1 2025 Earnings Call Highlights: Amrosi Launch Boosts Margins ...May 15, 2025 | finance.yahoo.comJourney Medical Corporation (DERM) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comJourney Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 14, 2025 | globenewswire.comJourney Medical (DERM) Projected to Post Earnings on WednesdayMay 13, 2025 | americanbankingnews.comJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025May 7, 2025 | globenewswire.comJourney Medical (DERM) to Release Earnings on MondayJourney Medical (NASDAQ:DERM) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-journey-medical-corporation-stock/)May 7, 2025 | marketbeat.comRamsey Alloush Sells 2,857 Shares of Journey Medical Co. (NASDAQ:DERM) StockMay 6, 2025 | insidertrades.comJourney Medical (NASDAQ:DERM) Shares Down 1.6% - What's Next?Journey Medical (NASDAQ:DERM) Stock Price Down 1.6% - Time to Sell?May 4, 2025 | marketbeat.comShort Interest in Journey Medical Co. (NASDAQ:DERM) Rises By 68.0%Journey Medical Co. (NASDAQ:DERM - Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 252,100 shares, a growth of 68.0% from the March 31st total of 150,100 shares. Based on an average daily trading volume, of 73,800 shares, the short-interest ratio is presently 3.4 days. Approximately 2.7% of the shares of the stock are sold short.May 1, 2025 | marketbeat.comWhy Journey Medical Corporation (DERM) is Surging in 2025April 30, 2025 | msn.comWhy These 15 Healthcare Stocks Are Surging in 2025April 30, 2025 | insidermonkey.comShort Interest in Journey Medical Co. (NASDAQ:DERM) Rises By 28.0%Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 150,100 shares, an increase of 28.0% from the March 15th total of 117,300 shares. Based on an average trading volume of 67,900 shares, the short-interest ratio is currently 2.2 days. Approximately 1.5% of the company's shares are short sold.April 21, 2025 | marketbeat.comIs Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?April 18, 2025 | msn.comJourney Medical promotes Ramsey Alloush to COOApril 2, 2025 | markets.businessinsider.comJourney Medical Corporation Appoints Ramsey Alloush as Chief Operating OfficerApril 1, 2025 | globenewswire.comFY2027 EPS Estimate for Journey Medical Decreased by AnalystJourney Medical Co. (NASDAQ:DERM - Free Report) - Equities researchers at B. Riley decreased their FY2027 earnings estimates for shares of Journey Medical in a research report issued to clients and investors on Thursday, March 27th. B. Riley analyst K. Patel now anticipates that the company willMarch 31, 2025 | marketbeat.comJourney Medical (NASDAQ:DERM) Announces Earnings ResultsJourney Medical (NASDAQ:DERM - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.30. Journey Medical had a negative return on equity of 132.10% and a negative net margin of 31.74%. The firm had revenue of $14.30 million for the quarter, compared to analysts' expectations of $14.21 million.March 29, 2025 | marketbeat.comB.Riley Financial Sticks to Their Buy Rating for Journey Medical Corp (DERM)March 29, 2025 | markets.businessinsider.comRoth Capital Predicts Higher Earnings for Journey MedicalJourney Medical Co. (NASDAQ:DERM - Free Report) - Analysts at Roth Capital upped their Q3 2025 earnings per share (EPS) estimates for shares of Journey Medical in a research note issued on Thursday, March 27th. Roth Capital analyst J. Wittes now expects that the company will post earnings of $0.1March 29, 2025 | marketbeat.comJourney Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call TranscriptMarch 28, 2025 | msn.comJourney Medical reports FY24 EPS (72c) vs (21c) last yearMarch 28, 2025 | markets.businessinsider.comJourney Medical price target lowered to $10.50 from $11 at Alliance Global PartnersMarch 27, 2025 | markets.businessinsider.comJourney Medical Corporation (DERM) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | seekingalpha.comJourney Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate HighlightsMarch 26, 2025 | globenewswire.comJourney Medical launches Emrosi for the treatment of rosaceaMarch 26, 2025 | finance.yahoo.comJourney Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of RosaceaMarch 24, 2025 | globenewswire.comShort Interest in Journey Medical Co. (NASDAQ:DERM) Expands By 20.5%Journey Medical Co. (NASDAQ:DERM - Get Free Report) saw a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 113,400 shares, a growth of 20.5% from the February 13th total of 94,100 shares. Currently, 1.3% of the company's shares are short sold. Based on an average daily volume of 69,600 shares, the days-to-cover ratio is presently 1.6 days.March 19, 2025 | marketbeat.comJourney Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025March 19, 2025 | globenewswire.comJourney Medical (DERM) to Release Quarterly Earnings on ThursdayJourney Medical (NASDAQ:DERM) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comClaude Maraoui Sells 49,271 Shares of Journey Medical Co. (NASDAQ:DERM) StockJourney Medical Co. (NASDAQ:DERM - Get Free Report) CEO Claude Maraoui sold 49,271 shares of the business's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $5.01, for a total value of $246,847.71. Following the transaction, the chief executive officer now owns 2,003,147 shares in the company, valued at approximately $10,035,766.47. This represents a 2.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 12, 2025 | marketbeat.comJourney Medical Corporation to Participate in the 37th Annual ROTH ConferenceMarch 12, 2025 | globenewswire.comJourney Medical Co. (NASDAQ:DERM) CEO Claude Maraoui Sells 14,905 SharesJourney Medical Co. (NASDAQ:DERM - Get Free Report) CEO Claude Maraoui sold 14,905 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $5.01, for a total value of $74,674.05. Following the completion of the sale, the chief executive officer now directly owns 2,052,418 shares of the company's stock, valued at $10,282,614.18. The trade was a 0.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 11, 2025 | marketbeat.comInsider Selling: Journey Medical Co. (NASDAQ:DERM) CEO Sells 14,905 Shares of StockMarch 11, 2025 | insidertrades.comInsider Selling: Journey Medical Co. (NASDAQ:DERM) CEO Sells 18,147 Shares of StockJourney Medical Co. (NASDAQ:DERM - Get Free Report) CEO Claude Maraoui sold 18,147 shares of Journey Medical stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $5.13, for a total value of $93,094.11. Following the sale, the chief executive officer now directly owns 2,092,874 shares of the company's stock, valued at $10,736,443.62. This trade represents a 0.86 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.March 6, 2025 | marketbeat.comInsider Selling: Journey Medical Co. (NASDAQ:DERM) CEO Sells 23,508 Shares of StockJourney Medical Co. (NASDAQ:DERM - Get Free Report) CEO Claude Maraoui sold 23,508 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $5.19, for a total value of $122,006.52. Following the sale, the chief executive officer now owns 2,139,922 shares in the company, valued at approximately $11,106,195.18. This represents a 1.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 6, 2025 | marketbeat.comInsider Selling: Journey Medical Co. (NASDAQ:DERM) CEO Sells 18,147 Shares of StockMarch 6, 2025 | insidertrades.comJourney Medical announces results from MVOR-1, MVOR-2 trials publishedMarch 5, 2025 | markets.businessinsider.comJourney Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat RosaceaMarch 5, 2025 | globenewswire.comJourney Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, FloridaMarch 4, 2025 | globenewswire.comJourney Medical Corporation (DERM): A Bull Case TheoryFebruary 20, 2025 | msn.comJourney Medical Co. (NASDAQ:DERM) Short Interest UpdateJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 83,800 shares, a growth of 6.5% from the January 15th total of 78,700 shares. Based on an average daily trading volume, of 80,800 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.8% of the company's stock are short sold.February 20, 2025 | marketbeat.comRoth MKM Remains a Buy on Journey Medical Corp (DERM)February 7, 2025 | markets.businessinsider.comJourney Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last weekFebruary 5, 2025 | finance.yahoo.comShort Interest in Journey Medical Co. (NASDAQ:DERM) Grows By 14.8%Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 76,800 shares, an increase of 14.8% from the December 31st total of 66,900 shares. Approximately 0.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 108,900 shares, the days-to-cover ratio is presently 0.7 days.February 1, 2025 | marketbeat.comJourney Medical Corporation: Emrosi's Launch Could Be A Turning PointJanuary 30, 2025 | seekingalpha.com Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address DERM Media Mentions By Week DERM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DERM News Sentiment▼0.220.65▲Average Medical News Sentiment DERM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DERM Articles This Week▼152▲DERM Articles Average Week Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dianthus Therapeutics News Today ChromaDex News Today Iovance Biotherapeutics News Today GH Research News Today AbCellera Biologics News Today AnaptysBio News Today KalVista Pharmaceuticals News Today Arbutus Biopharma News Today Bicycle Therapeutics News Today Xencor News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DERM) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.